Struggling to manage complex appeals workflows.
Molecular lab appeals require complete documentation, payer-specific evidence, and disciplined follow-up to recover revenue at scale.
Molecular lab appeals require complete documentation, payer-specific evidence, and disciplined follow-up to recover revenue at scale.
Limited visibility into denials, underpayments, and payer performance leaves revenue opportunities undiscovered and financial performance at risk.
Medical records, prior authorizations, and appeals create documentation-intensive workflows that delay reimbursement and consume valuable staff resources.
TELCOR RCM combines automation, configurability, and real-time revenue intelligence to simplify complex reimbursement and maximize financial performance.
Recover more denied revenue with payer-specific documentation, streamlined appeals, and disciplined follow-up.
TELCOR's laboratory experts understand molecular reimbursement while giving executives complete visibility into revenue performance, productivity, and payer activity.
TELCOR AI Systems automates document-intensive workflows including medical records, intake, prior authorizations, and appeals to accelerate reimbursement.
Molecular reimbursement depends on complete clinical documentation, medical necessity, prior authorizations, and evolving payer policies. TELCOR AI Systems applies intelligent automation to the documentation behind every claim, strengthening high-value reimbursement while reducing manual effort.
Purpose-built for laboratory revenue cycle management, TELCOR AI Systems identifies documentation that supports medical necessity, detects missing information before it delays reimbursement, prepares prior authorizations and appeals, and uncovers payer and documentation trends that impact financial performance. Your experts remain in command by defining business rules, managing exceptions, and approving payer submissions.
The result is stronger front-end claim quality, fewer manual touchpoints, faster reimbursement, and more time focused on protecting high-value molecular revenue.
Increase in processed requisitions.
Months to achieve a return on investment.
Improvement in productivity resulting from automated rules and staff reallocation.
Yes. Molecular laboratories manage complex reimbursement requirements that can vary by test, payer, plan, diagnosis, and patient history. Prior authorization, medical necessity documentation, MolDX requirements, Z-Codes, evolving coverage policies, and heightened payer scrutiny can all affect reimbursement. TELCOR provides the technology, expertise, and configurable workflows molecular laboratories need to navigate these requirements and protect revenue.
TELCOR helps laboratories identify potential claim issues before submission through configurable validations, medical necessity checks, payer-specific rules, and automated workflow controls. Laboratories can also track denial trends, manage appeals, and identify recurring issues by payer, test, or reason code. This helps improve first-pass claim quality while giving teams the information needed to address the root causes of denials.
TELCOR provides real-time visibility into claims, payments, denials, adjustments, underpayments, prior authorization activity, and accounts receivable. Detailed dashboards and reporting allow laboratory leaders to evaluate performance by payer, plan, test, client, location, and other key variables. This level of insight helps teams understand net yield, identify revenue leakage, and make more informed operational and contracting decisions.
Yes. Molecular laboratories can use TELCOR revenue cycle management software with their internal billing team or partner with TELCOR for comprehensive billing services. Our U.S.-based specialists manage complex laboratory billing workflows while providing the transparency, reporting, and accountability laboratories need to maintain control over their revenue cycle.
Results vary based on each laboratory’s payer mix, testing portfolio, workflows, and starting performance. TELCOR helps laboratories strengthen claim quality, improve collections, reduce manual work, accelerate reimbursement, and gain greater control over denials and underpayments. Our analytics can also help laboratories evaluate reimbursement and profitability at the payer, test, and client levels.
Molecular laboratories choose TELCOR because our solutions are built specifically for the complexity of MolDX reimbursement. TELCOR combines configurable technology, experienced billing professionals, transparent reporting, and dedicated support to help laboratories adapt as payer policies and reimbursement requirements change.
Explore white papers, guides, and insights designed to support your revenue cycle management success.
Talk to us today to see how TELCOR empowers molecular labs to unlock greater efficiency, accuracy, and financial success.